HIV associated nephropathy cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
Overview
The World Health Organization (WHO) data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.[1] There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
Cost-effectiveness of Therapy
Cost-effectiveness of Therapy
- There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
- The World Health Organization (WHO) data on HIV/AIDS is as the following for 2018:[1]
- People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018
- Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH